No clinically relevant hypersensitivity reactions in clinical trials with tralokinumab in asthma

M. Carlsson (Mölndal, Sweden), M. Braddock (Cambridge, United Kingdom), Y. Li (Gaithersburg, United States of America), J. Wang (Gaithersburg, United States of America), W. Xu (Gaithersburg, United States of America), G. Colice (Gaithersburg, United States of America)

Source: International Congress 2018 – New developments in the treatment of asthma
Session: New developments in the treatment of asthma
Session type: Thematic Poster
Number: 1034
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Carlsson (Mölndal, Sweden), M. Braddock (Cambridge, United Kingdom), Y. Li (Gaithersburg, United States of America), J. Wang (Gaithersburg, United States of America), W. Xu (Gaithersburg, United States of America), G. Colice (Gaithersburg, United States of America). No clinically relevant hypersensitivity reactions in clinical trials with tralokinumab in asthma. 1034

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: